Repligen (NASDAQ:RGEN – Get Free Report) and Anavex Life Sciences (NASDAQ:AVXL – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends. Profitability This table compares Repligen and Anavex Life […]
Exscientia (NASDAQ:EXAI – Get Free Report) and Repligen (NASDAQ:RGEN – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership. Analyst Recommendations This is a summary of recent recommendations and […]
Repligen (NASDAQ:RGEN – Get Free Report) and Exscientia (NASDAQ:EXAI – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk and valuation. Volatility & Risk Repligen has a beta of 1.01, indicating […]
The net worth of the chromatography resin industry’s market share is expected to increase from US$ 1.4 billion in 2023 to more than US$ 2.8 billion by 2033. From 2023 to 2033, the market for Chromatography Resin is expected to grow at a 7.5% CAGR. Growth in the market is primarily driven by an increase in biosimilar.
ESOMAR-certified consulting firm Future Market Insights’ report projects the global chromatography resin market to rise at an impressive pace between 2021 and 2031. Growing adoption of affinity chromatography resin technology is expected to increase the demand of chromatography resins across the globe. Alongside thi.